Skip to main content
SpringerLink
Log in

Psychological Co-morbidities of Cardiovascular Disease

  • Chapter
  • First Online:
Psychological Co-morbidities of Physical Illness

  • 1045 Accesses

Abstract

Cardiovascular disease (CVD) is the leading cause of death in the U.S. and other developed nations. Because CVD often cooccurs with various mental disorders, healthcare providers responsible for either physical or mental health should be aware of how these conditions influence each other and the implications for treatment. This chapter reviews the prevalence and pathophysiology of the associations between CVD and mental disorders, reviews the literature on assessment, treatment, clinical considerations, and makes recommendations for areas in need of further research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbas, C. C., Schmid, J. P., Guler, E., Wiedemar, L., Begre, S., Saner, H., et al. (2009). Trajectory of posttraumatic stress disorder caused by myocardial infarction: A two-year follow-up study. International Journal of Psychiatry in Medicine, 39(4), 359–376.

    PubMed  Google Scholar 

  • Agelink, M. W., Boz, C., Ullrich, H., & Andrich, J. (2002). Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment. Psychiatry Research, 113(1–2), 139–149.

    PubMed  Google Scholar 

  • Aina, Y., & Susman, J. L. (2006). Understanding comorbidity with depression and anxiety disorders. Journal of the American Osteopathic Association, 106(Suppl 2), S9–S14.

    PubMed  Google Scholar 

  • Amani, R. (2007). Is dietary pattern of schizophrenia patients different from healthy subjects? BMC Psychiatry, 7, 15.

    PubMed  Google Scholar 

  • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists & North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27(2), 596–601.

    Google Scholar 

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Association.

    Google Scholar 

  • Anda, R. F., Williamson, D. F., Escobedo, L. G., Mast, E. E., Giovino, G. A., & Remington, P. L. (1990). Depression and the dynamics of smoking – A national perspective. Journal of the American Medical Association, 264(12), 1541–1545.

    PubMed  CAS  Google Scholar 

  • Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002). Mortality of patients with mood disorders: Follow-up over 34–38 years. Journal of Affective Disorders, 68(2–3), 167–181.

    PubMed  CAS  Google Scholar 

  • Bankier, B., Januzzi, J. L., & Littman, A. B. (2004). The high prevalence of multiple psychiatric disorders in stable outpatients with coronary heart disease. Psychosomatic Medicine, 66(5), 645–650.

    PubMed  Google Scholar 

  • Bansal, B., Khan, M., & Salhan, A. K. (2009). A review of measurement and analysis of heart rate variability. International conference on computer and automation engineering, 8–10 March, pp. 243–246.

    Google Scholar 

  • Bar, K. J., Boettger, M. K., Koschke, M., Schulz, S., Chokka, P., Yeragani, V. K., et al. (2007). Non-linear complexity measures of heart rate variability in acute schizophrenia. Clinical Neurophysiology, 118(9), 2009–2015.

    PubMed  Google Scholar 

  • Bar, K. J., Greiner, W., Jochum, T., Friedrich, M., Wagner, G., & Sauer, H. (2004). The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. Journal of Affective Disorders, 82(2), 245–252.

    PubMed  Google Scholar 

  • Bar, K. J., Koschke, M., Boettger, M. K., Berger, S., Kabisch, A., Sauer, H., et al. (2007). Acute psychosis leads to increased QT variability in patients suffering from schizophrenia. Schizophrenia Research, 95(1–3), 115–123.

    PubMed  Google Scholar 

  • Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004). Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis. Psychosomatic Medicine, 66(6), 802–813.

    PubMed  Google Scholar 

  • Bastien, D. L. (2010). Pharmacological treatment of combat-induced PTSD: A literature review. British Journal of Nursing (Mark Allen Publishing), 19(5), 318–321.

    Google Scholar 

  • Baune, B. T., Adrian, I., Arolt, V., & Berger, K. (2006). Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychotherapy and Psychosomatics, 75(5), 319–326.

    PubMed  Google Scholar 

  • Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.

    PubMed  CAS  Google Scholar 

  • Bell, R. C., Farmer, S., Ries, R., & Srebnik, D. (2009). Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics. Psychiatric Services, 60(12), 1686–1689.

    PubMed  Google Scholar 

  • Berg, A., Lonnqvist, J., Palomaki, H., & Kaste, M. (2009). Assessment of depression after stroke a comparison of different screening instruments. Stroke, 40(2), 523–529.

    PubMed  Google Scholar 

  • Berkman, L. F., Blumenthal, J., Burg, M., Carney, R. M., Catellier, D., Cowan, M. J., et al. (2003). Effects of treating depression and low-perceived social support on clinical events after myocardial infarction – The enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. Journal of the American Medical Association, 289(23), 3106–3116.

    PubMed  Google Scholar 

  • Berntson, G. G., Bigger, J. T., Eckberg, D. L., Grossman, P., Kaufmann, P. G., Malik, M., et al. (1997). Heart rate variability: Origins, methods, and interpretive caveats. Psychophysiology, 34(6), 623–648.

    PubMed  CAS  Google Scholar 

  • Bhogal, S. K., Teasell, R., Foley, N., & Speechley, M. (2004). Lesion location and poststroke depression – Systematic review of the methodological limitations in the literature. Stroke, 35(3), 794–802.

    PubMed  Google Scholar 

  • Bigger, J. T., Fleiss, J. L., Rolnitzky, L. M., & Steinman, R. C. (1993). The ability of several short-term measures of RR variability to predict mortality after myocardial-infarction. Circulation, 88(3), 927–934.

    PubMed  CAS  Google Scholar 

  • Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale – An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77.

    PubMed  Google Scholar 

  • Blasco-Fontecilla, H., Baca-Garcia, E., & de Leon, J. (2010). Do atypical antipsychotic drugs reduce the risk of ischemic heart disease and mortality? Possible role of 5-HT2A receptor blockade. Schizophrenia Research, 119(1–3), 160–163.

    PubMed  Google Scholar 

  • Bonnet, F., Irving, K., Terra, J. L., Nony, P., Berthezene, F., & Moulin, P. (2005). Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis, 178(2), 339–344.

    PubMed  CAS  Google Scholar 

  • Bradford, D. W., Kim, M. M., Braxton, L. E., Marx, C. E., Butterfield, M., & Elbogen, E. B. (2008). Access to medical care among persons with psychotic and major affective disorders. Psychiatric Services, 59(8), 847–852.

    PubMed  Google Scholar 

  • Brar, J. S., Ganguli, R., Pandina, G., Turkoz, I., Berry, S., & Mahmoud, R. (2005). Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. The Journal of Clinical Psychiatry, 66(2), 205–212.

    PubMed  Google Scholar 

  • Bresee, L. C., Majumdar, S. R., Patten, S. B., & Johnson, J. A. (2010). Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study. Schizophrenia Research, 117(1), 75–82.

    PubMed  Google Scholar 

  • Bruce, E. C., & Musselman, D. L. (2005). Depression, alterations in platelet function, and ischemic heart disease. Psychosomatic Medicine, 67, S34–S36.

    PubMed  Google Scholar 

  • Callaghan, R. C., Boire, M. D., Lazo, R. G., McKenzie, K., & Cohn, T. (2009). Schizophrenia and the incidence of cardiovascular morbidity: A population-based longitudinal study in Ontario, Canada. Schizophrenia Research, 115(2–3), 325–332.

    PubMed  Google Scholar 

  • Capasso, R. M., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & Sauver, J. S. (2008). Mortality in schizophrenia and schizoaffective disorder: An Olmsted county, Minnesota cohort: 1950–2005. Schizophrenia Research, 98(1–3), 287–294.

    PubMed  Google Scholar 

  • Carney, R. M., Blumenthal, J. A., Freedland, K. E., Stein, P. K., Howells, W. B., Berkman, L. F., et al. (2005). Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Archives of Internal Medicine, 165(13), 1486–1491.

    PubMed  Google Scholar 

  • Carney, R. M., & Freedland, K. E. (2008). Depression in patients with coronary heart disease. The American Journal of Medicine, 121(11 Suppl 2), S20–S27.

    PubMed  Google Scholar 

  • Carney, R. M., & Freedland, K. E. (2009). Depression and heart rate variability in patients with coronary heart disease. Cleveland Clinic Journal of Medicine, 76(Suppl 2), S13–S17.

    PubMed  Google Scholar 

  • Carney, R. M., Freedland, K. E., & Jaffe, A. S. (2009). Depression screening in patients with heart disease. Journal of the American Medical Association, 301(13), 1337.

    PubMed  CAS  Google Scholar 

  • Carrizo, E., Fernandez, V., Quintero, J., Connell, L., Rodriguez, Z., Mosquera, M., et al. (2008). Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives. Schizophrenia Research, 103(1–3), 83–93.

    PubMed  Google Scholar 

  • Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685–716.

    PubMed  CAS  Google Scholar 

  • Chang, H. H., Yang, Y. K., Gean, P. W., Huang, H. C., Chen, P. S., & Lu, R. B. (2010). The role of valproate in metabolic disturbances in bipolar disorder patients. Journal of Affective Disorders, 124(3), 319–323.

    PubMed  CAS  Google Scholar 

  • Chen, C. K., Chen, Y. C., & Huang, Y. S. (2009). Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: A 12-month follow up. Psychiatry and Clinical Neurosciences, 63(1), 17–22.

    PubMed  Google Scholar 

  • Chen, Y. H., Hu, C. J., Lee, H. C., & Lin, H. C. (2010). An Increased risk of stroke among panic disorder patients: A 3-year follow-up study. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 55(1), 43–49.

    PubMed  Google Scholar 

  • Cohen, H. W., Gibson, G., & Alderman, M. H. (2000). Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. The American Journal of Medicine, 108(1), 2–8.

    PubMed  CAS  Google Scholar 

  • Daughters, S. B., Braun, A. R., Sargeant, M. N., Reynolds, E. K., Hopko, D. R., Blanco, C., et al. (2008). Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: The life enhancement treatment for substance use (LETS Act!). The Journal of Clinical Psychiatry, 69(1), 122–129.

    PubMed  Google Scholar 

  • Daumit, G. L., Goff, D. C., Meyer, J. M., Davis, V. G., Nasrallah, H. A., McEvoy, J. P., et al. (2008). Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia Research, 105(1–3), 175–187.

    PubMed  Google Scholar 

  • Daumit, G. L., Goldberg, R. W., Anthony, C., Dickerson, F., Brown, C. H., Kreyenbuhl, J., et al. (2005). Physical activity patterns in adults with severe mental illness. The Journal of Nervous and Mental Disease, 193(10), 641–646.

    PubMed  Google Scholar 

  • Davidson, K. W., Kupfer, D. J., Bigger, J. T., Califf, R. M., Carney, R. M., Coyne, J. C., et al. (2006). Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report. Psychosomatic Medicine, 68(5), 645–650.

    PubMed  CAS  Google Scholar 

  • Davidson, K. W., Rieckmann, N., Clemow, L., Schwartz, J. E., Shimbo, D., Medina, V., et al. (2010). Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms coronary psychosocial evaluation studies randomized controlled trial. Archives of Internal Medicine, 170(7), 600–608.

    PubMed  Google Scholar 

  • Davies, S. J. C., Jackson, P. R., Potokar, J., & Nutt, D. J. (2004). Treatment of anxiety and depressive disorders in patients with cardiovascular disease. British Medical Journal, 328(7445), 939–943.

    PubMed  Google Scholar 

  • De Hert, M., Kalnicka, D., van Winkel, R., Wampers, M., Hanssens, L., Van Eyck, D., et al. (2006). Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder. The Journal of Clinical Psychiatry, 67(12), 1889–1896.

    PubMed  Google Scholar 

  • de Jonge, P., Honig, A., van Melle, J. P., Schene, A. H., Kuyper, A. M. G., Tulner, D., et al. (2007). Nonresponse to treatment for depression following myocardial infarction: Association with subsequent cardiac events. The American Journal of Psychiatry, 164(9), 1371–1378.

    PubMed  Google Scholar 

  • De Leon, J., & Diaz, F. J. (2007). Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: The clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy. Schizophrenia Research, 96(1–3), 185–197.

    PubMed  Google Scholar 

  • Deacon, B. J., & Abramowitz, J. S. (2004). Cognitive and behavioral treatments for anxiety disorders: A review of meta-analytic findings. Journal of Clinical Psychology, 60(4), 429–441.

    PubMed  Google Scholar 

  • Dedert, E., Calhoun, P., Watkins, L., Sherwood, A., & Beckham, J. (2010). Posttraumatic stress disorder, cardiovascular, and metabolic disease: A review of the evidence. Annals of Behavioral Medicine, 39(1), 61–78.

    PubMed  Google Scholar 

  • Dell’Osso, B., Buoli, M., Baldwin, D. S., & Altamura, A. C. (2010). Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: A comprehensive review of their clinical efficacy. Human Psychopharmacology-Clinical and Experimental, 25(1), 17–29.

    PubMed  Google Scholar 

  • Diaz, F. J., James, D., Botts, S., Maw, L., Susce, M. T., & de Leon, J. (2009). Tobacco smoking behaviors in bipolar disorder: A comparison of the general population, schizophrenia, and major depression. Bipolar Disorders, 11(2), 154–165.

    PubMed  Google Scholar 

  • Diaz, F. J., Meary, A., Arranz, M. J., Ruano, G., Windemuth, A., & de Leon, J. (2009). Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels. Schizophrenia Research, 115(2–3), 136–140.

    PubMed  Google Scholar 

  • Dimidjian, S., & Davis, K. J. (2009). Newer variations of cognitive-behavioral therapy: Behavioral activation and mindfulness-based cognitive therapy. Current Psychiatry Reports, 11, 453–458.

    PubMed  Google Scholar 

  • Druss, B. G., Bradford, W. D., Rosenheck, R. A., Radford, M. J., & Krumholz, H. M. (2001). Quality of medical care and excess mortality in older patients with mental disorders. Archives of General Psychiatry, 58(6), 565–572.

    PubMed  CAS  Google Scholar 

  • Eze-Nliam, C. M., Thombs, B. D., Lima, B. B., Smith, C. G., & Ziegelstein, R. C. (2010). The association of depression with adherence to antihypertensive medications: A systematic review. Journal of Hypertension, 28(9), 1785–1795.

    PubMed  CAS  Google Scholar 

  • Fan, A. Z., Strine, T. W., Jiles, R., & Mokdad, A. H. (2008). Depression and anxiety associated with cardiovascular disease among persons aged 45 years and older in 38 states of the United States. Preventive Medicine, 46(5), 445–450.

    PubMed  Google Scholar 

  • Fang, J., & Cheng, Q. (2009). Etiological mechanisms of post-stroke depression: A review. Neurological Research, 31(9), 904–909.

    PubMed  Google Scholar 

  • Felker, B., Yazel, J. J., & Short, D. (1996). Mortality and medical comorbidity among psychiatric patients: A review. Psychiatric Services, 47(12), 1356–1363.

    PubMed  CAS  Google Scholar 

  • Fiedorowicz, J. G., Solomon, D. A., Endicott, J., Leon, A. C., Li, C. S., Rice, J. P., et al. (2009). Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosomatic Medicine, 71(6), 598–606.

    PubMed  Google Scholar 

  • Fleet, R., Lavoie, K., & Beitman, B. D. (2000). Is panic disorder associated with coronary artery disease? A critical review of the literature. Journal of Psychosomatic Research, 48(4–5), 347–356.

    PubMed  CAS  Google Scholar 

  • Flegal, K. M., Carroll, M. D., & Ogden, C. L. (2010). Prevalence and trends in obesity among US Adults, 1999–2008. Journal of the American Medical Association, 303(3), 235–241.

    PubMed  CAS  Google Scholar 

  • Ford, E. S., Giles, W. H., & Dietz, W. H. (2002). Prevalence of the metabolic syndrome among US adults: Findings from the third national Health and Nutrition Examination Survey. Journal of the American Medical Association, 287, 356–359.

    PubMed  Google Scholar 

  • Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., et al. (2010). Antidepressant drug effects and depression severity a patient-level meta-analysis. Journal of the American Medical Association, 303(1), 47–53.

    PubMed  CAS  Google Scholar 

  • Frasure-Smith, N., & Lesperance, F. (2010). Depression and cardiac risk: Present status and future directions. Heart, 96(3), 173–176.

    PubMed  Google Scholar 

  • Garcia-Portilla, M. P., Saiz, P. A., Bascaran, M. T., Martinez, S., Benabarre, A., Sierra, P., et al. (2009). Cardiovascular risk in patients with bipolar disorder. Journal of Affective Disorders, 115(3), 302–308.

    PubMed  Google Scholar 

  • Glassman, A. H., Bigger, J. T., Gaffney, M., Shapiro, P. A., & Swenson, J. R. (2006). Onset of major depression associated with acute coronary syndromes – Relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Archives of General Psychiatry, 63(3), 283–288.

    PubMed  Google Scholar 

  • Glassman, A. H., O’Connor, C. M., Califf, R. M., Swedberg, K., Schwartz, P., Bigger, J. T., et al. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association, 288(6), 701–709.

    PubMed  CAS  Google Scholar 

  • Gleason, P. P., Schulz, R., Smith, N. L., Newsom, J. T., Kroboth, P., Kroboth, F. J., et al. (1998). Correlates and prevalence of benzodiazepine use in community-dwelling elderly. Journal of General Internal Medicine, 13(4), 243–250.

    PubMed  CAS  Google Scholar 

  • Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., et al. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80(1), 45–53.

    PubMed  Google Scholar 

  • Goldstein, B. I., Fagiolini, A., Houck, P., & Kupfer, D. J. (2009). Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disorders, 11(6), 657–662.

    PubMed  Google Scholar 

  • Goodwin, R. D., Davidson, K. W., & Keyes, K. (2009). Mental disorders and cardiovascular disease among adults in the United States. Journal of Psychiatric Research, 43(3), 239–246.

    PubMed  Google Scholar 

  • Grippo, A. J. (2009). Mechanisms underlying altered mood and cardiovascular dysfunction: The value of neurobiological and behavioral research with animal models. Neuroscience and Biobehavioral Reviews, 33(2), 171–180.

    PubMed  CAS  Google Scholar 

  • Guler, E., Schmid, J. P., Wiedemar, L., Saner, H., Schnyder, U., & von Kanel, R. (2009). Clinical diagnosis of posttraumatic stress disorder after myocardial infarction. Clinical Cardiology, 32(3), 125–129.

    PubMed  Google Scholar 

  • Gulliksson, M., Burell, G., Vessby, B., Lundin, L., Toss, H., & Svardsudd, K. (2011). Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care Project (SUPRIM). Archives of Internal Medicine, 171(2), 134–140.

    PubMed  Google Scholar 

  • Hackett, M. L., Anderson, C. S., House, A., & Xia, J. (2008). Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews (4), CD003437.

    Google Scholar 

  • Hambridge, J. A., Turner, A., & Baker, A. L. (2009). BraveHeart begins: Pilot results of group cognitive behaviour therapy for depression and anxiety in cardiac patients. The Australian and New Zealand Journal of Psychiatry, 43(12), 1171–1177.

    PubMed  Google Scholar 

  • Hari, R., Begre, S., Schmid, J. P., Saner, H., Gander, M. L., & von Kanel, R. (2010). Change over time in posttraumatic stress caused by myocardial infarction and predicting variables. Journal of Psychosomatic Research, 69(2), 143–150.

    PubMed  Google Scholar 

  • Harter, M., Woll, S., Wunsch, A., Bengel, J., & Reuter, K. (2006). Screening for mental disorders in cancer, cardiovascular, and musculoskeletal diseases. Social Psychiatry and Psychiatric Epidemiology, 41, 56–62.

    PubMed  Google Scholar 

  • Haupt, D. W., Rosenblatt, L. C., Kim, E., Baker, R. A., Whitehead, R., & Newcomer, J. W. (2009). Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. The American Journal of Psychiatry, 166(3), 345–353.

    PubMed  Google Scholar 

  • Hennekens, C. H. (2007). Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. The Journal of Clinical Psychiatry, 68(Suppl 4), 4–7.

    PubMed  Google Scholar 

  • Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005). Schizophrenia and increased risks of cardiovascular disease. American Heart Journal, 150(6), 1115–1121.

    PubMed  Google Scholar 

  • Herrmann, C. (1997). International experiences with the hospital anxiety and depression scale – A review of validation data and clinical results. Journal of Psychosomatic Research, 42, 17–41.

    PubMed  CAS  Google Scholar 

  • Herrmann, C., Brand-Driehorst, S., Buss, U., & Rüger, U. (2000). Effects of anxiety and depression on 5-year mortality in 5057 patients referred for exercise testing. Journal of Psychosomatic Research, 48(4–5), 455–462.

    PubMed  CAS  Google Scholar 

  • Hippisley-Cox, J., Parker, C., Coupland, C., & Vinogradova, Y. (2007). Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: A cross-sectional study. Heart, 93(10), 1256–1262.

    PubMed  Google Scholar 

  • Hippisley-Cox, J., Pringle, M., Hammersley, V., Crown, N., Wynn, A., Meal, A., et al. (2001). Antidepressants as risk factor for ischaemic heart disease: Case-control study in primary care. British Medical Journal, 323(7314), 666–669.

    PubMed  CAS  Google Scholar 

  • Hirschfeld, R. M. A., Williams, J. B. W., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., et al. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The mood disorder questionnaire. The American Journal of Psychiatry, 157(11), 1873–1875.

    PubMed  CAS  Google Scholar 

  • Hoffman, E. J., & Mathew, S. J. (2008). Anxiety disorders: A comprehensive review of pharmacotherapies. The Mount Sinai Journal of Medicine, 75(3), 248–262.

    Google Scholar 

  • Hopko, D. R., Lejuez, C. W., & Hopko, S. D. (2008). Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behavior Therapy, 39, 126–136.

    PubMed  Google Scholar 

  • Hopko, D. R., Lejuez, C. W., LePage, J. P., Hopko, S. D., & McNeil, D. W. (2003). A brief behavioral activation treatment for depression: A randomized trial within an inpatient psychiatric hospital. Behavior Modification, 27, 458–469.

    PubMed  Google Scholar 

  • Huffman, J. C., & Stern, T. A. (2003). The use of benzodiazepines in the treatment of chest pain: A review of the literature. The Journal of Emergency Medicine, 25(4), 427–437.

    PubMed  Google Scholar 

  • Ibishi, N. F., Musliu, N. R., Kamberi, A., Qirko, S., Brokaj, S., Lezha, M., et al. (2009). Impact of depression and cardiovascular disease. Psychiatric Annals, 39(1), 22–25.

    Google Scholar 

  • Jacka, F. N., Pasco, J. A., Mykletun, A., Williams, L. J., Hodge, A. M., O’Reilly, S. L., et al. (2010). Association of Western and traditional diets with depression and anxiety in women. The American Journal of Psychiatry, 167(3), 305–311.

    PubMed  Google Scholar 

  • Janeway, D. (2009). An Integrated approach to the diagnosis and treatment of anxiety within the practice of cardiology. Cardiology in Review, 17(1), 36–43.

    PubMed  Google Scholar 

  • Janszky, I., Ahnve, S., Lundberg, I., & Hemmingsson, T. (2010). Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. Journal of the American College of Cardiology, 56(1), 31–37.

    PubMed  Google Scholar 

  • Jindal, R., MacKenzie, E. M., Baker, G. B., & Yeragani, V. K. (2005). Cardiac risk and schizophrenia. Journal of Psychiatry & Neuroscience, 30(6), 393–395.

    Google Scholar 

  • Joynt, K. E., & O’Connor, C. M. (2005). Lessons from SADHART, ENRICHD, and other trials. Psychosomatic Medicine, 67, S63–S66.

    PubMed  Google Scholar 

  • Kemp, A. H., Quintana, D. S., Gray, M. A., Felmingham, K. L., Brown, K., & Gatt, J. M. (2010). Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biological Psychiatry, 67(11), 1067–1074.

    PubMed  CAS  Google Scholar 

  • Kent, L. K., & Shapiro, P. A. (2009). Depression and related psychological factors in heart disease. Harvard Review of Psychiatry, 17(6), 377–388.

    PubMed  Google Scholar 

  • Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627.

    PubMed  Google Scholar 

  • Ketter, T. A. (2010). Strategies for monitoring outcomes in patients with bipolar disorder. The Primary Care Companion to the Journal of Clinical Psychiatry, 12(Suppl 1), 10–16.

    Google Scholar 

  • Kilbourne, A. M., Post, E. P., Nossek, A., Drill, L., Cooley, S., & Bauer, M. S. (2008). Improving medical and psychiatric outcomes among individuals with bipolar disorder: A randomized controlled trial. Psychiatric Services, 59(7), 760–768.

    PubMed  Google Scholar 

  • Kilbourne, A. M., Post, E. P., Nossek, A., Sonel, E., Drill, L. J., Cooley, S., et al. (2008). Service delivery in older patients with bipolar disorder: A review and development of a medical care model. Bipolar Disorders, 10(6), 672–683.

    PubMed  Google Scholar 

  • Kilbourne, A. M., Rofey, D. L., McCarthy, J. F., Post, E. P., Welsh, D., & Blow, F. C. (2007). Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disorders, 9(5), 443–452.

    PubMed  Google Scholar 

  • Kim, J. Y., & Lee, H. W. (2007). Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. Epilepsia, 48(7), 1366–1370.

    PubMed  CAS  Google Scholar 

  • Kop, W. J., & Gottdiener, J. S. (2005). The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosomatic Medicine, 67, S37–S41.

    PubMed  Google Scholar 

  • Koponen, H., Jokelainen, J., Keinanen-Kiukaanniemi, S., Kumpusalo, E., & Vanhala, M. (2008). Metabolic syndrome predisposes to depressive symptoms: A population-based 7-year follow-up study. The Journal of Clinical Psychiatry, 69(2), 178–182.

    PubMed  Google Scholar 

  • Koschke, M., Boettger, M. K., Schulz, S., Berger, S., Terhaar, J., Voss, A., et al. (2009). Autonomy of autonomic dysfunction in major depression. Psychosomatic Medicine, 71(8), 852–860.

    PubMed  Google Scholar 

  • Krantz, D. S., Whittaker, K. S., Francis, J. L., Rutledge, T., Johnson, B. D., Barrow, G., et al. (2009). Psychotropic medication use and risk of adverse cardiovascular events in women with suspected coronary artery disease: Outcomes from the Women’s Ischemia Syndrome Evaluation (WISE) study. Heart, 95(23), 1901–1906.

    PubMed  CAS  Google Scholar 

  • Kreyenbuhl, J., Dickerson, F. B., Medoff, D. R., Brown, C. H., Goldberg, R. W., Fang, L., et al. (2006). Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. The Journal of Nervous and Mental Disease, 194(6), 404–410.

    PubMed  Google Scholar 

  • Kronish, I. M., Rieckmann, N., Halm, E. A., Shimbo, D., Vorchheimer, D., Haas, D. C., et al. (2006). Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. Journal of General Internal Medicine, 21(11), 1178–1183.

    PubMed  Google Scholar 

  • Kronish, I. M., Rieckmann, N., Schwartz, J. E., Schwartz, D. R., & Davidson, K. W. (2009). Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality? Psychosomatic Medicine, 71(7), 697–703.

    PubMed  Google Scholar 

  • Kubzansky, L. D., Koenen, K. C., Jones, C., & Eaton, W. W. (2009). A prospective study of posttraumatic stress disorder symptoms and coronary heart disease in women. Health Psychology, 28(1), 125–130.

    PubMed  Google Scholar 

  • Kubzansky, L. D., Koenen, K. C., Spiro, A., Vokonas, P. S., & Sparrow, D. (2007). Prospective study of posttraumatic stress disorder symptoms and coronary heart disease in the normative aging study. Archives of General Psychiatry, 64, 110–116.

    Google Scholar 

  • Kuczmarski, M. F., Sees, A. C., Hotchkiss, L., Cotugna, N., Evans, M. K., & Zonderman, A. B. (2010). Higher healthy eating index-2005 scores associated with reduced symptoms of depression in an urban population: Findings from the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) study. Journal of the American Dietetic Association, 110(3), 383–389.

    PubMed  Google Scholar 

  • Kuijpers, P., Hamulyak, K., Strik, J., Wellens, H. J. J., & Honig, A. (2002). Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry Research, 109(2), 207–210.

    PubMed  CAS  Google Scholar 

  • Kwon, J. S., Choi, J. S., Bahk, W. M., Yoon Kim, C., Hyung Kim, C., Chul Shin, Y., et al. (2006). Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. The Journal of Clinical Psychiatry, 67(4), 547–553.

    PubMed  Google Scholar 

  • Lesperance, F., Frasure-Smith, N., Koszycki, D., Laliberte, M. A., van Zyl, L. T., Baker, B., et al. (2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease – The Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. Journal of the American Medical Association, 297(4), 367–379.

    PubMed  CAS  Google Scholar 

  • Licht, C. M. M., De Geus, E. J. C., Van Dyck, R., & Penninx, B. W. J. H. (2010). Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biological Psychiatry, 68(9), 861–868.

    PubMed  CAS  Google Scholar 

  • Licht, C. M. M., de Geus, E. J. C., Zitman, F. G., Hoogendijk, W. J. G., van Dyck, R., & Penninx, B. W. J. H. (2008). Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Archives of General Psychiatry, 65(12), 1358–1367.

    PubMed  Google Scholar 

  • Lincoln, N. B., & Flannaghan, T. (2003). Cognitive behavioral psychotherapy for depression following stroke – A randomized controlled trial. Stroke, 34(1), 111–115.

    PubMed  CAS  Google Scholar 

  • Lindamer, L. A., McKibbin, C., Nonnan, G. J., Jordan, L., Harrison, K., Abeyesinhe, S., et al. (2008). Assessment of physical activity in middle-aged and older adults with schizophrenia. Schizophrenia Research, 104(1–3), 294–301.

    PubMed  Google Scholar 

  • Lindenmayer, J. P., Khan, A., Wance, D., Maccabee, N., Kaushik, S., & Kaushik, S. (2009). Outcome evaluation of a structured educational wellness program in patients with severe mental illness. The Journal of Clinical Psychiatry, 70(10), 1385–1396.

    PubMed  Google Scholar 

  • Ljubic, M. A., Deane, F. P., Zecchin, R. P., & Denniss, R. (2006). Motivation, psychological distress, and exercise adherence following myocardial infarction. Australian Journal of Rehabilitation Counseling, 12(1), 21–32.

    Google Scholar 

  • Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., et al. (1996). Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation, 93(5), 1043–1065.

    Google Scholar 

  • Markovitz, J. H., Matthews, K. A., Wing, R. R., Kuller, L. H., & Meilahn, E. N. (1991). Psychological, biological and health behavior predictors of blood pressure changes in middle-aged women. Journal of Hypertension, 9(5), 399–406.

    PubMed  CAS  Google Scholar 

  • Martens, E. J., de Jonge, P., Na, B., Cohen, B. E., Lett, H., & Whooley, M. A. (2010). Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease the heart and soul study. Archives of General Psychiatry, 67(7), 750–758.

    PubMed  Google Scholar 

  • McConnell, S., Jacka, F. N., Williams, L. J., Dodd, S., & Berk, M. (2005). The relationship between depression and cardiovascular disease. International Journal of Psychiatry in Clinical Practice, 9(3), 157–167.

    Google Scholar 

  • McConnell, S. D., Inderbitzin, L. B., & Pollard, W. E. (1992). Primary health care in the CMHC: A role for the nurse practitioner. Hospital and Community Psychiatry, 43(7), 724–727.

    PubMed  CAS  Google Scholar 

  • McEvoy, J. P., Meyer, J. M., Goff, D. C., Nasrallah, H. A., Davis, S. M., Sullivan, L., et al. (2005). Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research, 80(1), 19–32.

    PubMed  Google Scholar 

  • McIntosh, A., Cohen, A., Turnbull, N., Esmonde, L., Dennis, P., Eatock, J., et al. (2004). Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder. Sheffield: National Collaborating Centre for Primary Care.

    Google Scholar 

  • McKibbin, C. L., Patterson, T. L., Norman, G., Patrick, K., Jin, H., Roesch, S., et al. (2006). A lifestyle intervention for older schizophrenia patients with diabetes mellitus: A randomized controlled trial. Schizophrenia Research, 86(1–3), 36–44.

    PubMed  Google Scholar 

  • McManus, D., Pipkin, S. S., & Whooley, M. A. (2005). Screening for depression in patients with coronary heart disease (data from the heart and soul study). The American Journal of Cardiology, 96(8), 1076–1081.

    PubMed  Google Scholar 

  • Meyer, J. M., Davis, V. G., Goff, D. C., McEvoy, J. P., Nasrallah, H. A., Davis, S. M., et al. (2008). Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1. Schizophrenia Research, 101(1–3), 273–286.

    PubMed  Google Scholar 

  • Meyer, J. M., & Koro, C. E. (2004). The effects of antipsychotic therapy on serum lipids: A comprehensive review. Schizophrenia Research, 70(1), 1–17.

    PubMed  Google Scholar 

  • Meyer, T., Buss, U., & Herrmann-Lingen, C. (2010). Role of cardiac disease severity in the predictive value of anxiety for all-cause mortality. Psychosomatic Medicine, 72(1), 9–15.

    PubMed  Google Scholar 

  • Mitchell, P. H., Veith, R. C., Becker, K. J., Buzaitis, A., Cain, K. C., Fruin, M., et al. (2009). Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant living well with stroke: Randomized, controlled trial. Stroke, 40(9), 3073–3078.

    PubMed  CAS  Google Scholar 

  • Morrato, E. H., Newcomer, J. W., Kamat, S., Baser, O., Harnett, J., & Cuffel, B. (2009). Metabolic screening after the American diabetes association’s consensus statement on antipsychotic drugs and diabetes. Diabetes Care, 32(6), 1037–1042.

    PubMed  CAS  Google Scholar 

  • Murray, D. P., Weiner, M., Prabhakar, M., & Fiedorowicz, J. G. (2009). Mania and mortality: Why the excess cardiovascular risk in bipolar disorder? Current Psychiatry Reports, 11(6), 475–480.

    PubMed  Google Scholar 

  • Mykletun, A., Bjerkeset, O., Dewey, M., Prince, M., Overland, S., & Stewart, R. (2007). Anxiety, depression, and cause-specific mortality: The HUNT study. Psychosomatic Medicine, 69(4), 323–331.

    PubMed  Google Scholar 

  • Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., et al. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86(1–3), 15–22.

    PubMed  Google Scholar 

  • Newcomer, J. W. (2009). Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses. The Journal of Clinical Psychiatry, 70, 30–36.

    PubMed  Google Scholar 

  • Newcomer, J. W., & Haupt, D. W. (2006). The metabolic effects of antipsychotic medications. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 51(8), 480–491.

    PubMed  Google Scholar 

  • Norton, P. J., & Price, E. C. (2007). A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. The Journal of Nervous and Mental Disease, 195(6), 521–531.

    PubMed  Google Scholar 

  • O’Connor, C. M., Jiang, W., Kuchibhatla, M., Silva, S. G., Cuffe, M. S., Callwood, D. D., et al. (2010). Safety and efficacy of sertraline for depression in patients with heart failure. Journal of the American College of Cardiology, 56(9), 692–699.

    PubMed  Google Scholar 

  • Olafiranye, O., Jean-Louis, G., Magai, C., Zizi, F., Brown, C. D., Dweck, M., et al. (2010). Anxiety and cardiovascular symptoms: The modulating role of insomnia. Cardiology, 115(2), 114–119.

    PubMed  CAS  Google Scholar 

  • Olfson, M., Fireman, B., Weissman, M., Leon, A. C., Sheehan, D. V., Kathol, R. G., et al. (1997). Mental disorders and disability among patients in a primary care group practice. The American Journal of Psychiatry, 154(12), 1734–1740.

    PubMed  CAS  Google Scholar 

  • Osborn, D. P., Nazareth, I., & King, M. B. (2007). Physical activity, dietary habits and coronary heart disease risk factor knowledge amongst people with severe mental illness: A cross sectional comparative study in primary care. Social Psychiatry and Psychiatric Epidemiology, 42(10), 787–793.

    PubMed  Google Scholar 

  • Ozeki, Y., Fujii, K., Kurimoto, N., Yamada, N., Okawa, M., Aoki, T., et al. (2010). QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34(2), 401–405.

    CAS  Google Scholar 

  • Peter, H., Goebel, P., Müller, S., & Hand, I. (1999). Clinically relevant cholesterol elevation in anxiety disorders: A comparison with normal controls. International Journal of Behavioral Medicine, 6(1), 30–39.

    PubMed  CAS  Google Scholar 

  • Pollock, B. G., Laghrissi-Thode, F., & Wagner, W. R. (2000). Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology, 20(2), 137–140.

    PubMed  CAS  Google Scholar 

  • Potokar, J. P., & Nutt, D. J. (2000). Chest pain: Panic attack or heart attack? International Journal of Clinical Practice, 54(2), 110–114.

    PubMed  CAS  Google Scholar 

  • Pozuelo, L., Zhang, J. P., Franco, K., Tesar, G., Penn, M., & Jiang, W. (2009). Depression and heart disease: What do we know, and where are we headed? Cleveland Clinic Journal of Medicine, 76(1), 59–70.

    PubMed  Google Scholar 

  • Qureshi, S. U., Pyne, J. M., Magruder, K. M., Schulz, P. E., & Kunik, M. E. (2009). The link between post-traumatic stress disorder and physical comorbidities: A systematic review. Psychiatry Quarterly, 80, 87–97.

    Google Scholar 

  • Rafanelli, C., Milaneschi, Y., Roncuzzi, R., & Pancaldi, L. G. (2010). Dysthymia before myocardial infarction as a cardiac risk factor at 2.5-year follow-up. Psychosomatics, 51(1), 8–13.

    PubMed  Google Scholar 

  • Rieckmann, N., Gerin, W., Kronish, I. M., Burg, M. M., Chaplin, W. F., Kong, G., et al. (2006). Course of depressive symptoms and medication adherence after acute coronary syndromes – An electronic medication monitoring study. Journal of the American College of Cardiology, 48(11), 2218–2222.

    PubMed  Google Scholar 

  • Rieckmann, N., Kronish, I. M., Haas, D., Gerin, W., Chaplin, W. F., Burg, M. M., et al. (2006). Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. American Heart Journal, 152(5), 922–927.

    PubMed  Google Scholar 

  • Roest, A. M., Martens, E. J., Denollet, J., & de Jonge, P. (2010). Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: A meta-analysis. Psychosomatic Medicine, 72(6), 563–569.

    PubMed  Google Scholar 

  • Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., et al. (2008). Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30(3), 208–225.

    PubMed  Google Scholar 

  • Rozanski, A., & Kubzansky, L. D. (2005). Psychologic functioning and physical health: A paradigm of flexibility. Psychosomatic Medicine, 67, S47–S53.

    PubMed  Google Scholar 

  • Rugulies, R. (2002). Depression as a predictor for coronary heart disease – A review and meta-analysis. American Journal of Preventive Medicine, 23(1), 51–61.

    PubMed  Google Scholar 

  • Rutledge, T., Reis, V. A., Linke, S. E., Greenberg, B. H., & Mills, P. J. (2006). Depression in heart failure – A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. Journal of the American College of Cardiology, 48(8), 1527–1537.

    PubMed  Google Scholar 

  • Sagen, U., Finset, A., Moum, T., Morland, T., Vik, T. G., Nagy, T., et al. (2010). Early detection of patients at risk for anxiety, depression and apathy after stroke. General Hospital Psychiatry, 32(1), 80–85.

    PubMed  Google Scholar 

  • Sagen, U., Vik, T. G., Moum, T., Morland, T., Finset, A., & Dammen, T. (2009). Screening for anxiety and depression after stroke: Comparison of the Hospital Anxiety and Depression Scale and the Montgomery and Asberg Depression Rating Scale. Journal of Psychosomatic Research, 67(4), 325–332.

    PubMed  Google Scholar 

  • Salaycik, K. J., Kelly-Hayes, M., Beiser, A., Nguyen, A. H., Brady, S. M., Kase, C. S., et al. (2007). Depressive symptoms and risk of stroke – The Framingham study. Stroke, 38(1), 16–21.

    PubMed  Google Scholar 

  • Santos, M., Koevari, E., Gold, G., Bozikas, V. P., Hof, P. R., Bouras, C., et al. (2009). The neuroanatomical model of post-stroke depression: Towards a change of focus? Journal of the Neurological Sciences, 283(1–2, Sp. Iss. 1), 158–162.

    Google Scholar 

  • Schelling, G. (2007). Post-traumatic stress disorder in somatic disease: Lessons from critically ill patients. In E. R. DeKloet & E. Vermetten (Eds.), Stress hormones and post traumatic stress disorder: Basic studies and clinical perspectives (pp. 229–237). Amsterdam: Elsevier.

    Google Scholar 

  • Scherrer, J. F., Chrusciel, T., Zeringue, A., Garfield, L. D., Hauptman, P. J., Lustman, P. J., et al. (2010). Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed veterans administration patients. American Heart Journal, 159(5), 772–779.

    PubMed  Google Scholar 

  • Scherrer, J. F., Xian, H., Bucholz, K. K., Eisen, S. A., Lyons, M. J., Goldberg, J., et al. (2003). A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosomatic Medicine, 65(4), 548–557.

    PubMed  Google Scholar 

  • Scott, J. (2004). Pathophysiology and biochemistry of cardiovascular disease. Current Opinion in Genetics and Development, 14(3), 271–279.

    PubMed  CAS  Google Scholar 

  • Serebruany, V. L., O’Connor, C. M., & Gurbel, P. A. (2001). Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. The American Journal of Cardiology, 87(12), 1398–1400.

    PubMed  CAS  Google Scholar 

  • Sherbourne, C. D., Jackson, C. A., & Meredith, L. S. (1996). Prevalence of comorbid anxiety disorders in primary care outpatients. Archives of Family Medicine, 5(1), 27–34.

    PubMed  CAS  Google Scholar 

  • Sigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370.

    Google Scholar 

  • Skala, J. A., Freedland, K. E., & Carney, R. M. (2006). Coronary heart disease and depression: A review of recent mechanistic research. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 51(12), 738–745.

    PubMed  Google Scholar 

  • Smoller, J. W., Allison, M., Cochrane, B. B., Curb, J. D., Perlis, R. H., Robinson, J. G., et al. (2009). Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Archives of Internal Medicine, 169(22), 2128–2139.

    PubMed  Google Scholar 

  • Soh, K. C., & Lee, C. (2010). Panic attack and its correlation with acute coronary syndrome – More than just a diagnosis of exclusion. Annals of the Academy of Medicine, Singapore, 39(3), 197–202.

    PubMed  Google Scholar 

  • Soreca, I., Frank, E., & Kupfer, D. J. (2009). The phenomenology of bipolar disorder: What drives the high rate of medical burden and determines long-term prognosis? Depression and Anxiety, 26(1), 73–82.

    PubMed  Google Scholar 

  • Sowden, G. L., & Huffman, J. C. (2009). The impact of mental illness on cardiac outcomes: A review for the cardiologist. International Journal of Cardiology, 132(1), 30–37.

    PubMed  Google Scholar 

  • Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1970). Manual for the state-trait anxiety inventory. Paolo Alto: Consulting Psychologists Press.

    Google Scholar 

  • Spindler, H., & Pedersen, S. S. (2005). Posttraumatic stress disorder in the wake of heart disease: Prevalence, risk factors, and future research directions. Psychosomatic Medicine, 67(5), 715–723.

    PubMed  Google Scholar 

  • Spitzer, C., Barnow, S., Volzke, H., John, U., Freyberger, H. J., & Grabe, H. J. (2009). Trauma, posttraumatic stress disorder, and physical illness: Findings from the general population. Psychosomatic Medicine, 71(9), 1012–1017.

    PubMed  Google Scholar 

  • Stein, P. K., & Kleiger, R. E. (1999). Insights from the study of heart rate variability. Annual Review of Medicine, 50, 249–261.

    PubMed  CAS  Google Scholar 

  • Stewart, J. C., Rand, K. L., Muldoon, M. F., & Kamarck, T. W. (2009). A prospective evaluation of the directionality of the depression-inflammation relationship. Brain, Behavior, and Immunity, 23(7), 936–944.

    PubMed  CAS  Google Scholar 

  • Strine, T. W., Mokdad, A. H., Balluz, L. S., Gonzalez, O., Crider, R., Berry, J. T., et al. (2008). Depression and anxiety in the united states: Findings from the 2006 behavioral risk factor surveillance system. Psychiatric Services, 59(12), 1383–1390.

    PubMed  Google Scholar 

  • Suls, J., & Bunde, J. (2005). Anger, anxiety, and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective dispositions. Psychological Bulletin, 131(2), 260–300.

    PubMed  Google Scholar 

  • Swenson, J. R., Doucette, S., & Fergusson, D. (2006). Adverse cardiovascular events in antidepressant trials involving high-risk patients: A systematic review of randomized trials. Canadian Journal of Psychiatry-Revue Canadienne De Psychiatrie, 51(14), 923–929.

    PubMed  Google Scholar 

  • Teri, L., Logsdon, R. G., & McCurry, S. M. (2005). The Seattle protocols: Advances in behavioral treatment of Alzheimer’s disease. In M. Grundman, H. Feldman, L. J. Fitten, B. Winblad, & E. Giacobini (Eds.), Research and practice in Alzheimer’s disease (pp. 153–158). Paris: Serdi.

    Google Scholar 

  • Thayer, J. F., & Lane, R. D. (2007). The role of vagal function in the risk for cardiovascular disease and mortality. Biological Psychology, 74(2), 224–242.

    PubMed  Google Scholar 

  • Thombs, B. D., de Jonge, P., Coyne, J. C., Whooley, M. A., Frasure-Smith, N., Mitchell, A. J., et al. (2008). Depression screening and patient outcomes in cardiovascular care a systematic review. Journal of the American Medical Association, 300(18), 2161–2171.

    PubMed  CAS  Google Scholar 

  • Thorndike, A. N., Regan, S., McKool, K., Pasternak, R. C., Swartz, S., Torres-Finnerty, N., et al. (2008). Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Archives of Internal Medicine, 168(2), 186–191.

    PubMed  Google Scholar 

  • Towle, D., Lincoln, N. B., & Mayfield, L. M. (1989). Evaluation of social work on depression after stroke. Clinical Rehabilitation, 3(2), 89–96.

    Google Scholar 

  • Vahia, I. V., Diwan, S., Bankole, A. O., Kehn, M., Nurhussein, M., Ramirez, P., et al. (2008). Adequacy of medical treatment among older persons with schizophrenia. Psychiatric Services, 59(8), 853–859.

    PubMed  Google Scholar 

  • van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G. P., Ormel, J., van Veldhuisen, D. J., et al. (2004). Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis. Psychosomatic Medicine, 66(6), 814–822.

    PubMed  Google Scholar 

  • Van Zyl, L. T., Hasegawa, T., & Nagata, K. (2008). Effects of antidepressant treatment on heart rate variability in major depression: A quantitative review. BioPsychoSocial Medicine, 2, 12.

    PubMed  Google Scholar 

  • Vogelzangs, N., Seldenrijk, A., Beekman, A. T. F., van Hout, H. P. J., de Jonge, P., & Penninx, B. (2010). Cardiovascular disease in persons with depressive and anxiety disorders. Journal of Affective Disorders, 125(1–3), 241–248.

    PubMed  Google Scholar 

  • Watkins, C. L., Auton, M. F., Deans, C. F., Dickinson, H. A., Jack, C. I. A., Lightbody, C. E., et al. (2007). Motivational interviewing early after acute stroke – A randomized, controlled trial. Stroke, 38(3), 1004–1009.

    PubMed  Google Scholar 

  • Wells, K. B., Golding, J. M., & Burnam, M. A. (1989). Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. General Hospital Psychiatry, 11(5), 320–327.

    PubMed  CAS  Google Scholar 

  • White, K. S. (2008). Cardiovascular disease and anxiety. In M. J. Zvolensky & J. A. Smith (Eds.), Anxiety in health behaviors and physical illness (pp. 279–315). New York: Springer.

    Google Scholar 

  • Whooley, M. A., de Jonge, P., Vittinghoff, E., Otte, C., Moos, R., Carney, R. M., et al. (2008). Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. Journal of the American Medical Association, 300(20), 2379–2388.

    PubMed  CAS  Google Scholar 

  • Williams, E. D., & Steptoe, A. (2007). The role of depression in the etiology of acute coronary syndrome. Current Psychiatry Reports, 9(6), 486–492.

    PubMed  Google Scholar 

  • World Health Organization. (2007). International statistical classification of diseases and health-related problems: 10th revision, from http://apps.who.int/classifications/apps/icd/icd10online/. Retreived 2-1-11

  • Wu, M. K., Wang, C. K., Bai, Y. M., Huang, C. Y., & Lee, S. D. (2007). Outcomes of obese, clozapine-treated in patients with schizophrenia placed on a six-month diet and physical activity program. Psychiatric Services, 58(4), 544–550.

    PubMed  Google Scholar 

  • Wulsin, L. R., & Singal, B. M. (2003). Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosomatic Medicine, 65(2), 201–210.

    PubMed  Google Scholar 

  • Yilmaz, E., Dosan, Y., Gurgoze, M. K., & Gungor, S. (2001). Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children. Acta Neurologica Belgica, 101(4), 217–220.

    PubMed  CAS  Google Scholar 

  • Zavoreo, I., Basic-Kes, V., Bosnar-Puretic, M., & Demarin, V. (2009). Post-stroke depression. Acta Clinica Croatica, 48(3), 329–333.

    PubMed  Google Scholar 

  • Zhao, H. W., Zhou, C. X., Su, X. L., Xiao, X. C., & Guo, Y. (2004). Effect of a mental intervention on post-stroke depression and rehabilitation of neurological function. Chinese Journal of Clinical Rehabilitation, 8(13), 2408–2409.

    Google Scholar 

  • Ziedonis, D., Hitsman, B., Beckham, J., Zvolensky, M., Adler, L., Audrain-McGovern, J., et al. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10(12), 1691–1715.

    Google Scholar 

  • Ziegelstein, R. C., Kim, S. Y., Kao, D., Fauerbach, J. A., Thombs, B. D., McCann, U., et al. (2005). Can doctors and nurses recognize depression in patients hospitalized with an acute myocardial infarction in the absence of formal screening? Psychosomatic Medicine, 67(3), 393–397.

    PubMed  Google Scholar 

  • Zwanzger, P., Diemer, J., & Jabs, B. (2009). Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: Controversial viewpoints and clinical perspectives. Journal of Neural Transmission, 116(6), 759–765.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, 55 Lake Avenue North S7-746, Worcester, MA, 01655, USA

    Matthew C. Whited PhD

  2. Department of Psychology, West Virginia University, Morgantown, WV, USA

    Amanda L. Wheat MS

  3. Departments of Preventive Medicine and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA

    Bradley M. Appelhans PhD

  4. University of Massachusetts Medical School, Worcester, MA, USA

    Sherry Pagoto PhD

Authors
  1. Matthew C. Whited PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda L. Wheat MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bradley M. Appelhans PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sherry Pagoto PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew C. Whited PhD .

Editor information

Editors and Affiliations

  1. Medical School, Div. Preventive & Behavioral Medicine, University of Massachusetts, N. Lake Ave. 55, Worcester, 01655, Massachusetts, USA

    Sherry Pagoto

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Whited, M.C., Wheat, A.L., Appelhans, B.M., Pagoto, S. (2011). Psychological Co-morbidities of Cardiovascular Disease. In: Pagoto, S. (eds) Psychological Co-morbidities of Physical Illness. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0029-6_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0029-6_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0030-2

  • Online ISBN: 978-1-4419-0029-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation